Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-04-16 | 2018-05-22 | 46006 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-04-16 | 2018-05-14 | 46024 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2018-04-16 | 2018-08-18 | 46046 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-05-31 | 2018-08-14 | 50961 |
APO-CEFPROZIL | 500MG | TABLET | Actual shortage | 2018-09-28 | 2018-09-28 | 62607 |
APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2018-10-11 | 2018-11-22 | 63807 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-10-19 | 2018-11-22 | 65005 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-11-30 | 2019-05-24 | 68231 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-12-12 | 2018-12-27 | 69315 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-01-28 | 69915 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2019-01-03 | 2019-01-28 | 71133 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2019-01-08 | 2019-02-14 | 71475 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2019-01-15 | 2019-04-26 | 72354 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2019-02-24 | 2019-03-08 | 76723 |
APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2019-03-05 | 2019-04-26 | 77899 |
APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-03 | 78526 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-13 | 78536 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-13 | 78541 |
APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2019-04-04 | 2019-11-05 | 80542 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-05-01 | 2019-06-17 | 82903 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |